← feed

Is NCT03421613 results overdue?

Yes — results are overdue. Primary completion was 2018-03-30; the FDAAA-801 reporting deadline (2019-03-30) passed 2686 days ago and no results are posted on ClinicalTrials.gov.

3VM1001 Cream for the Treatment of Pain Associated With Post Herpetic Neuralgia (PHN)

NCT IDNCT03421613 ↗
SponsorCDA Research Group, Inc. (INDUSTRY)
PhaseEARLY_PHASE1
StatusCOMPLETED
Primary completion2018-03-30 (ACTUAL)
Reporting deadline2019-03-30 (completion + 365d)
Days overdue2686
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 3a5df8a95808fd39… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03421613. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →